Dublin, August 24, 2021--(Business Wire)--The "Global Laparoscopic Gynecological Surgery Market 2021-2028" report has been added to ResearchAndMarkets.com's products.
By 2028, the global laparoscopic gynecological surgery market is expected to reach 36.13 billion U.S. dollars, with a compound annual growth rate of 6.7%
Increasing adoption of minimally invasive surgery, rising prevalence of gynecological diseases, technological advancement, favorable reimbursement policies and various government initiatives are key factors that promote market growth. The technological advancement of laparoscopic equipment is one of the main drivers of this market.
Many market participants are investing in research and development to develop innovative products. Technological advancements in laparoscopy, visualization systems, and other components have jointly promoted product demand.
These advancements include high-definition imaging, portability, and mini-laparoscopy, enabling accurate diagnosis and treatment. For example, the development and introduction of medical robots to assist doctors is a key advancement in this field.
These robots have many advantages, such as a 3D view of the surgical area, reduced blood loss and blood transfusion requirements, early discharge, minimal scarring and less trauma to the body, as well as the surgeon's tremor due to the higher accuracy of the elimination of surgery. The use of hand assist devices and robotic laparoscopic surgery is one of the new trends, driving market growth.
Some companies focus on innovations in manual access instruments, sliding lock grippers and trocars, and closure devices used in these procedures. For example, Stryker Corp.’s 5.0 mm sliding locking grasper provides various handles and insertion styles for grasping, dissecting, suturing, and cutting functions.
Aesculap's sliding locking gripper provides excellent organization and grip control. In addition, Nu-Tip Instruments manufactured by CooperSurgical Inc. has a reusable handle and disposable stainless steel tip, and allows scissors, grippers or dissectors to be made as needed. Therefore, technological advancements in design will promote the growth potential of the market.
Highlights of Laparoscopic Gynecological Surgery Market Report
In terms of application, due to the high prevalence of gynecological diseases, laparoscopic hysterectomy will have the largest share of income in 2020
In terms of end use, the hospital sector will account for the largest share of revenue in 2020
Segment growth is attributable to the increase in the number of laparoscopic surgeries performed in hospitals
North America is the leading regional market in 2020 and is expected to maintain its leading position throughout the forecast period
This increase is due to the high incidence of uterine cancer and the increase in the elderly population in the area
Chapter 4 Laparoscopic Gynecological Surgery Market Variables, Trends and Scope
4.2 Penetration and growth prospects
4.4.1.1 The global prevalence of gynecological diseases is rising
4.4.1.3 Increasing use of minimally invasive surgery instead of open surgery
4.4.2.1 High cost of laparoscopic equipment
4.4.2.2 Infrastructure gaps in developing economies supporting laparoscopic surgery
4.5 Market analysis tools for laparoscopic gynecological surgery
4.5.2 Porter's five forces analysis
4.6 Analysis of major transactions and strategic alliances
Chapter 5 Laparoscopic Gynecological Surgery Market: Segmentation Analysis, By Procedure, 2016-2028 (Million USD)
5.2 Analysis of surgical market share in 2020 and 2028
5.3 Laparoscopic gynecological surgery market, according to procedures, from 2016 to 2028
5.4 Market size forecast and trend analysis
5.4.3 Laparoscopic vaginal fixation (Sacrocolpopexy, Sacrocervicopexy, etc.)
5.4.5 Laparoscopic accessories (oophorectomy, salpingo-oophorectomy, etc.)
Chapter 6 Laparoscopic Gynecological Surgery Market: Segmentation Analysis, By End Use, 2016-2028 (Million USD)
6.2 Analysis of end-use market share in 2020 and 2028
6.3 Laparoscopic gynecological surgery market, by end use, 2016-2028
6.4 Market scale forecast and trend analysis
Chapter 7 Laparoscopic Gynecological Surgery Market: Regional Market Analysis, By Procedure, Procedure and End Use, 2016-2028 (Million USD)
7.2 Analysis of Regional Market Share in 2020 and 2028
7.4 Market size forecast and trend analysis
Chapter 8 Laparoscopic Gynecological Surgery Market: Competitive Analysis
Karl Storz SE & CO. kg
Shenzhen Mindray Biomedical Electronics Co., Ltd.
For more information about this report, please visit https://www.researchandmarkets.com/r/gk65u2
View the source version on businesswire.com: https://www.businesswire.com/news/home/20210824005486/en/
ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com US Eastern Time Office Hours Call 1-917-300-0470 US/Canada Toll Free 1-800-526-8630 GMT Office Hours Call 353-1-416-8900
Pras Subramanian of Yahoo Finance broke Rivian's upcoming IPO.
Synthetic biology expert Amyris (NASDAQ: AMRS) yesterday reported disappointing earnings results for the third quarter of 2021 after the market closed, failing to achieve profitability and profitability at the same time. In addition, investors are selling shares after learning that the company is raising funds through the issuance of priority convertible notes. Although the company's reported sales increased by 39.7% year-on-year, it does not seem to be enough to satisfy investors' appetite.
The Trade Desk (NASDAQ: TTD) share price climbed again on Tuesday, up 10.6%, but rose by 9.4% at the end of the trading day. The catalyst that drove the stock higher was a series of activities by Wall Street analysts who scrambled to update their price targets after The Trade Desk's impressive third-quarter financial results. Before the market opened on Monday, The Trade Desk announced better-than-expected quarterly results, which surprised some investors.
With the passage of the $1.2 trillion bipartisan infrastructure bill, all eyes in Washington are now turned to the $1.85 trillion "Rebuild Better" bill. Combining these two bills, Congress will invest more than $3 trillion in infrastructure, education, and climate...Continue reading → Biden’s "Better Rebuild Homes" post that can end these retirement loopholes first appeared on SmartAsset On the blog.
This afternoon (Tuesday, November 9th), the Clinical Trials for Alzheimer's Disease (CTAD) conference will open in Boston. Cassava Sciences (SAVA) will deliver a presentation in the next few days with the title of the poster "Interim results of an open-label study of Simufilam in mild to moderate Alzheimer's disease." B. Riley analyst Mayank Mamtani expects that the presentation will include a more comprehensive update to the top-line 12-month cognitive performance data released at the end of the third quarter. Remember,
In May of this year, the Dow Jones Industrial Average (DJINDICES: ^DJI) celebrated its 125th anniversary. The Dow Jones Index also happens to be home to some important value stocks. If you are looking for a smart place to put your money into work in November, then the following three Dow stocks will be very popular.
Nicholas Hyman, co-head of William Blair and a long-time GE analyst, explained what the latest reorganization means for the company and the companies that like it.
Brian Sozzi of Yahoo Finance discusses Roblox's earnings because the company has doubled its revenue and has focused its attention on Metaverse.
On Tuesday morning, Palantir Technologies (NYSE: PLTR) announced its third-quarter results, ranking first among defense IT companies. Palantir's stock price fell 10% in early trading and was down 8.8% as of 12:26 pm Eastern Time. Palantir is best known for its technology that helped find Osama bin Laden's company, which went public about a year ago and immediately soared because the market considered the potential commercial applications of its data analysis tools.
Tuesday was a terrible visit to the orthodontists at SmileDirectClub (NASDAQ: SDC). Teeth alignment experts released their latest quarterly data, and investors found these numbers to be very ugly. Although not every number in the SmileDirectClub's third quarter report is depressing, the most compelling items are not impressive.
With me today, Dr. Shankar Musunuri, Chairman, CEO and co-founder of Ocugen, will provide business updates; and Sanjay Subramanian, our Chief Financial Officer and Head of Corporate Development, who will provide financial updates. The call will also be recorded, and a replay of approximately 45 days will be provided in the investor section of the Ocugen website along with an accompanying slide show.
Coinbase Global Inc.'s share price hit a new closing high for two consecutive days before the quarterly earnings report on Tuesday, but the slowdown in cryptocurrency trading in the summer caused them to fall in the late trading.
Are you looking for undervalued stocks to buy? If so, Wall Street analysts believe that there are at least a few stocks in the healthcare industry that deserve more attention than they have recently received. Telemedicine, vaccines and genetic testing may make these stocks big winners in the future.
The electric car manufacturer’s stock pricing in its initial public offering has valued the company at more than $77 billion on a fully diluted basis.
After Canadian cannabis companies filed Form 12b-25 with the US Securities and Exchange Commission stating that they could not submit quarterly earnings reports on time, the shares of Cronos Group (NASDAQ: CRON) fell 16.5% in early trading on Tuesday. Cronos said it needs more time to determine how much impairment costs its cannabidiol (CBD) business will bear, but its goodwill and intangible assets will be hit by at least $220 million. Just yesterday, due to speculation that Altria will acquire marijuana stocks, its stock price soared.
The CEO made a big bet on Bitcoin. But he is not alone.
Yahoo Technology Editor Daniel Howley talked about the partnership between Luminar and Nvidia to develop self-driving car technology.
In-depth discussion Almost every investor is aware of the shortage of semiconductors and related equipment (including microprocessors and chips), but the demand is high. However, the stocks of this key group trade at relatively low prices relative to the broader stock market.
Plug Power raised its sales guidance for 2022 when it reported third-quarter data on Tuesday night. In any case, investors initially sold the stock.
In this article, we will discuss the 10 best mineral stocks to buy now. If you want to skip our detailed analysis of these stocks, please go directly to the 5 best mineral stocks to buy now. As demand for minerals exceeds supply in the post-pandemic economy, mining stocks have achieved incredible gains so far this year. according to[…]